bioRxiv. 2024 Feb 12. pii: 2024.02.09.579465. [Epub ahead of print]
Gregory P Williams,
Tanner Michaelis,
João Rodrigues Lima-Junior,
April Frazier,
Ngan K Tran,
Elizabeth J Phillips,
Simon A Mallal,
Irene Litvan,
Jennifer G Goldman,
Roy N Alcalay,
John Sidney,
David Sulzer,
Alessandro Sette,
Cecilia S Lindestam Arlehamn.
Parkinson's disease (PD) is associated with autoimmune T cells that recognize the protein alpha-synuclein in a subset of individuals. Multiple neuroantigens are targets of autoinflammatory T cells in classical central nervous system autoimmune diseases such as multiple sclerosis (MS). Here, we explored whether additional autoantigenic targets of T cells in PD. We generated 15-mer peptide pools spanning several PD-related proteins implicated in PD pathology, including GBA, SOD1, PINK1, parkin, OGDH, and LRRK2. Cytokine production (IFNγ, IL-5, IL-10) against these proteins was measured using a fluorospot assay and PBMCs from patients with PD and age-matched healthy controls. This approach identified unique epitopes and their HLA restriction from the mitochondrial-associated protein PINK1, a regulator of mitochondrial stability, as an autoantigen targeted by T cells. The T cell reactivity was predominantly found in male patients with PD, which may contribute to the heterogeneity of PD. Identifying and characterizing PINK1 and other autoinflammatory targets may lead to antigen-specific diagnostics, progression markers, and/or novel therapeutic strategies for PD.
Keywords: PINK1; Parkinson’s disease; T cell epitope; neuroantigen; neurodegenerative disease